...
首页> 外文期刊>Osteoporosis and Sarcopenia >Effects Of Bisphosphonate On Bone Metabolic Marker And Vertebral Fracture In Elderly Post-Menopausal Osteoporosis
【24h】

Effects Of Bisphosphonate On Bone Metabolic Marker And Vertebral Fracture In Elderly Post-Menopausal Osteoporosis

机译:双膦酸盐对绝经后骨质疏松症老年人骨代谢指标和椎骨骨折的影响

获取原文
           

摘要

longitudinal cohort studyThis longitudinal cohort study was to assess the trends of hip fractureincidence and pharmacologic treatment after hip fracture of person 50yr of age between 2003 and 2015 of National Health Insurance ServiceNational Sample Cohort (NHIS-NSC).Incidence of hip fracture increased in worldwide countries over recentyears. However, there were limited information for the incidence of hipfracture and pharmacologic treatment after hip fracture.The data managed by NHIS-NSC were used to identify the hip fractures inpatients aged >50 years between 2002 and 2015. Sex-specific incidencerate (per 100,000 person-years) were calculated based on that estimatedfor the Korea population (Korea Cencus 2011). And we calculated theproportion receiving the bisphosphonate after within 1 years after hipfracture.
机译:纵向队列研究这项纵向队列研究旨在评估国家健康保险服务机构国家样本队列(NHIS-NSC)在2003年至2015年间50岁以上人群髋部骨折后髋部骨折发生率和药物治疗的趋势。近年来。但是,关于髋部骨折后髋部骨折的发生率和药物治疗的信息有限。NHIS-NSC管理的数据用于识别2002年至2015年间年龄大于50岁的住院患者的髋部骨折。按性别分列的发生率(每100,000人年)是根据韩国人口的估算值计算得出的(Korea Cencus 2011)。并且我们计算了髋部骨折后1年内接受双膦酸盐治疗的比例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号